Blue Jet Healthcare Limited (NSE:BLUEJET)

India · Delayed Price · Currency is INR

606.30

-17.75 (-2.84%)

Jul 13, 2026, 3:30 PM IST

-33.26% (1Y)

Market Cap	105.17B -29.2%
Revenue (ttm)	9.47B -8.0%
Net Income	2.48B -18.8%
EPS	14.29 -18.8%
Shares Out	173.47M
PE Ratio	42.43
Forward PE	34.98
Dividend	1.20 (0.19%)
Ex-Dividend Date	Sep 19, 2025

Volume	1,288,541
Open	605.00
Previous Close	624.05
Day's Range	601.00 - 615.90
52-Week Range	325.00 - 1,027.80
Beta	0.77
Analysts	Buy
Price Target	501.00 (-17.37%)
Earnings Date	Jul 30, 2026

About Blue Jet Healthcare

Blue Jet Healthcare Limited engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products. It provides contrast media intermediates; niche pharmaceutical intermediates and APIs; and CDMO/CMO services, as well as end-to-end solutions from process development and commercialization of NCEs, advance intermediates, API, and building blocks. The company develops, manufactures, and markets saccharin and related salts. It has operations in India, Norw... [Read more]

Industry Biotechnology

Sector Healthcare

Founded 1968

Employees 196

Stock Exchange National Stock Exchange of India

Ticker Symbol BLUEJET

Full Company Profile

Financial Performance

In fiscal year 2026, Blue Jet Healthcare's revenue was 9.47 billion, a decrease of -8.03% compared to the previous year's 10.30 billion. Earnings were 2.48 billion, a decrease of -18.80%.

Financial Statements

Analyst Summary

According to 5 analysts, the average rating for BLUEJET stock is "Buy." The 12-month stock price target is ₹501.00, which is a decrease of -17.37% from the latest price.

Price Target

₹501.00

(-17.37% downside)

Analyst Consensus: Buy

Stock Forecasts